
Lentivirus Packaging
High-efficiency lentiviral vector production for gene delivery, CAR-T cell therapy, and cell line construction. Cyagen provides scalable solutions with strict quality control to ensure high-titer, high-purity lentivirus for your research.

Reliable & Ready-to-Use
Validated for stable gene expression and hard-to-infect cells.

Scalable High-Titer Production
Purified lentivirus (≤1×10⁹ TU/mL) for in vivo & in vitro use.

High Biosafety Standards
3rd-gen lentiviral system for safety & high efficiency.
Overview
Workflow
FAQs
Comprehensive Lentivirus Packaging for Reliable Gene Delivery
Lentiviral vectors provide an effective method for stable gene delivery, widely used in cell line engineering, gene therapy, and CAR-T applications. Cyagen offers a comprehensive lentivirus packaging service, covering overexpression, interference, and knockout applications. Our production system ensures high-quality, high-titer lentivirus with stringent quality control for both research and therapeutic applications.
With extensive experience in viral vector production, we provide scalable solutions that include purified, high-titer lentivirus suitable for both in vitro and in vivo applications. Our flexible service options cater to different experimental needs, allowing for custom vector construction and packaging strategies.
With extensive experience in viral vector production, we provide scalable solutions that include purified, high-titer lentivirus suitable for both in vitro and in vivo applications. Our flexible service options cater to different experimental needs, allowing for custom vector construction and packaging strategies.

Explore Ready-to-Use Mouse Models
Discover over 18,000 validated mouse strains—including knockout, conditional knockout, and humanized models—covering 20+ research areas such as oncology, neurology, and metabolism. All models are supported by detailed genotype data and guaranteed quality, helping you fast-track discovery with confidence.
You Might Also Be Interested In

Knockout Cell Lines Library
Browse validated human KO cell lines by gene or cell type

Tumor Cell Lines Library
Access characterized human tumor lines by cancer type or genetic status.

AAV Vectors Library
Search and order AAVs by serotype, gene, or function

MouseAtlas Model Library
Search and access curated genetically engineered mouse strains

Cell Immunotherapy CRO Platform
CAR-T/NK development with custom vectors, models, and in vivo validation

Gene Therapy CRO Platform
AI-guided AAV design and full-spectrum preclinical validation
Citation Database
Molecular Therapy: Methods & Clinical Development, March, 2025
Intracranial AAV administration dose-dependently recruits B cells to inhibit the AAV redosing
【Other】
Gut, February, 2025
E-twenty-six-specific sequence variant 5 (ETV5) facilitates hepatocellular carcinoma progression and metastasis through enhancing polymorphonuclear myeloid-derived suppressor cell (PMN-MDSC)-mediated immunosuppression
【Other】
Cell Death & Disease, February, 2025
Mcm5 mutation leads to silencing of Stat1-bcl2 which accelerating apoptosis of immature T lymphocytes with DNA damage
【Other】
Molecular Therapy, February, 2025
Single-cell data-driven design of armed oncolytic virus to boost cooperative innate-adaptive immunity against cancer
【Other】
Request a Virus Packaging Service Consultation
Get expert guidance for your viral vector production needs. Submit your project details and we'll assist you promptly.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
